Expression of Mesothelin in Thymic Carcinoma and its Potential Therapeutic Significance

OBJECTIVES: Advanced thymic epithelial tumors (TETs) lack adequate treatment options in part due to absence of well characterized tumor-specific antigens. Mesothelin, a cell surface antigen, has been used successfully as a target for tumor-directed therapy. We sought to determine tumor expression an...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Lung Cancer
Auteurs principaux: Thomas, Anish, Chen, Yuanbin, Berman, Arlene, Schrump, David S., Giaccone, Giuseppe, Pastan, Ira, Venzon, David J., Liewehr, David J., Steinberg, Seth M., Miettinen, Markku, Hassan, Raffit, Rajan, Arun
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7804607/
https://ncbi.nlm.nih.gov/pubmed/27794397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2016.09.015
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires